Stamford, CT -- (SBWIRE) -- 12/05/2013 -- High Rising Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: JPMorgan Chase & Co.(NYSE:JPM), Arena Pharmaceuticals, Inc.(NASDAQ:ARNA), Idera Pharmaceuticals Inc(NASDAQ:IDRA), North American Oil & Gas Corp(OTCBB:NAMG)
JPMorgan Chase & Co.(NYSE:JPM) opened the session at $56.44, remained amid the day range of $56.21 - $57.47, and closed the session at $57.19. The stock showed a positive performance of 0.58% in previous trading session. The stock gained a volume of 20.29 million shares and the average volume of the stock remained 18.71 million shares. JPMorgan Chase & Co., a financial holding company, provides various financial services worldwide. Its Consumer and Community Banking segment provides deposits, investment products and services, lending, and cash management and payment solutions to consumers and small businesses; mortgage origination and servicing; and residential mortgages and home equity loans.
Why Should Investors Buy JPM After The Recent Gain? Just Go Here and Find Out
Arena Pharmaceuticals, Inc.(NASDAQ:ARNA) traded with volume of 4.89 million shares in the prior session and the average volume of the stock remained 5.88 million shares. The 52 week range of the stock remained $4.05 - $11.00. The stock showed a negative movement of -1.06% and closed its session at $6.53. The market capitalization of the stock remained 1.43 billion. Arena Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases.
Why Should Investors Buy ARNA After the Recent Fall? Just Go Here and Find Out
Idera Pharmaceuticals Inc(NASDAQ:IDRA) exchanged 1.95 million shares and the average volume remained 877,399.00 shares. The stock escalated 21.89% and closed the session at $2.45. The beta of the stock remained 1.94 and the EPS of the stock remained -0.71. The shares outstanding of the stock remained 46.73 million. Idera Pharmaceuticals, Inc., a clinical stage biotechnology company, engages in the discovery and development of novel synthetic DNA- and RNA- based drug candidates. It is developing drug candidates designed to modulate immune responses mediated through Toll-like Receptors (TLRs); and evaluating gene silencing oligonucleotides (GSOs), which inhibit the production of disease-associated proteins by targeting RNA.
For How Long IDRA will fight for Profitability? Read This Trend Analysis report
North American Oil & Gas Corp(OTCBB:NAMG) gained volume of 855,816.00 shares, while the average volume remained 607,476.00 shares. The stock advanced 0.56% and finished the session Wednesday at $0.900. The EPS of the stock remained -0.03. The one month of the stock was -13.46% and three month trend remained negative -19.64%. North American Oil & Gas Corp. offers oil and gas production services. The company was founded in 2011 and is based in Ventura, California.
For How Long NAMG’s Gloss will Attract Investors? Find out via this report
High Rising Stocks provides investors with the hottest penny stock alerts on a regular basis. It carries Hot Penny Stocks and Penny Stock Newsletter, we will send you alerts through our Free Penny Stock Newsletters with High Yielding alerts, market forecasting, stock tips and strategies, and offer you the tools to help you along the way with the goal of keeping you loyal to our service.
Carriage Consulting Group, High Rising Stocks, their Members, officers, directors, employees, affiliates, or any other related person(s) (collectively, “High Rising Stocks”) are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. High Rising Stocks as defined are neither licensed nor qualified to provide investment advice and you are specifically and adamantly advised not to rely upon anything said/posted/communicated/implied or expressed by High Rising Stocks as defined.
Read full Disclaimer at: http://highrisingstocks.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)